• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FARAPULSE, INC. / BOSTON SCIENTIFIC CORPORATION FARAPULSE PFA ABLATION SYSTEM FARAWAVE; PERCUTANEOUS CARDIAC ABLATION CATHETER FOR TREATMENT OF ATRIAL FIBRILLATION WITH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FARAPULSE, INC. / BOSTON SCIENTIFIC CORPORATION FARAPULSE PFA ABLATION SYSTEM FARAWAVE; PERCUTANEOUS CARDIAC ABLATION CATHETER FOR TREATMENT OF ATRIAL FIBRILLATION WITH Back to Search Results
Patient Problem Necrosis (1971)
Event Date 03/19/2024
Event Type  Injury  
Event Description
Hemodialysis due to heme-related acute tubular necrosis after pulsed field ablation for atrial fibrillation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FARAPULSE PFA ABLATION SYSTEM FARAWAVE
Type of Device
PERCUTANEOUS CARDIAC ABLATION CATHETER FOR TREATMENT OF ATRIAL FIBRILLATION WITH
Manufacturer (Section D)
FARAPULSE, INC. / BOSTON SCIENTIFIC CORPORATION
MDR Report Key18960393
MDR Text Key338489374
Report NumberMW5153063
Device Sequence Number1
Product Code QZI
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/21/2024
Patient Sequence Number1
Patient Outcome(s) Other; Hospitalization; Life Threatening;
-
-